Fuda Cancer Hospital - Philippines

Fuda Cancer Hospital - Philippines Fuda is committed to providing cancer patients around the world with the best medical care.

Fuda Cancer Hospital is considered one of the BEST cancer hospitals in China by patients and is affiliated to Jinan University and Translational Medicine Center Fuda Cancer Hospital South District and Fuda Cancer Hospital North District (collectively, “Fuda Cancer Hospital”) are located in Guangzhou, in the south of China. Both hospitals are modern and specialized cancer centers that are recognize

d for their minimally invasive therapies and innovative treatments that provide an effective alternative to the traditional treatment of chemotherapy/radiation/surgery. Fuda Cancer Hospital is affiliated with the Chinese Academy of Sciences’ Guangzhou Institute of Biomedicine and Health. The hospitals are teaching hospitals of Jinan University School of Medicine. In 2010, the central government designated the hospitals as nationally important clinics and awarded a five million RMB grant to them. The honorary president of the hospital is Academician Mengchao Wu, and the president is Professor Kecheng Xu, a renowned and highly respected specialist of general oncology and gastroenterology. Fuda Cancer Hospital focuses on the diagnosis and treatment of liver, lung, breast, nasopharyngeal, colorectal, uterus, stomach, esophageal, pancreatic, tongue, prostate, skin, larynx, and lymphoma cancers, as well as many others. The hospital insists on providing patient care and services and adopting an individualized approach in the treatment of patients based on their individual conditions. By combining conventional treatment with newly developed technologies and traditional Chinese medicine, the hospital is equipped to treat patients with a complete spectrum of available therapies, from the traditional to the cutting-edge. Besides the conventional treatments for cancer (surgery, chemotherapy and radiotherapy) the hospital has brought together innovative and proven new technologies such as Nano Knife Therapy, Interventional Hepasphere, cryosurgical ablation (CSA), vascular interventional therapy, Cancer Microvessel Intervention (CMI), photodynamic therapy, seed knife brachytherapy, radiofrequency ablation and bioimmunotherapy. The hospital prides itself on using a “3C+P” approach when treating patients: CSA, CMI, combined immunotherapy for cancer (CIC), and personalized therapy. So far, Fuda Cancer Hospital has performed more than 10,000 cases of cryosurgical ablation, and it performs the most number of cryosurgical ablations annually in the world. Dr. Franco Lugnani, the president of the International Society of Cryosurgery, has lauded Fuda for its efforts. Furthermore, the International Society of Cryosurgery designated the hospital as a training center for doctors from the Asian-Pacific region who are interested in cryosurgery. The hospital’s concept and diagnostic techniques have gained a great reputation from countries throughout southeast Asia, as well as the United States, the United Kingdom, Spain, Denmark, Netherlands, and other countries.

30/04/2026

APR.30.2026.
.
[Minimally Invasive Treatment] [Liver Metastases – Cryoablation]
>>>Patient with Sigmoid Colon Cancer: Cryoablation of Liver Metastases> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

Apr.23.2026.  . [Fuda News] [Thailand – Hospital Visit]Friends from Afar! Thai Medical Experts Visit Fuda for Exchange a...
23/04/2026

Apr.23.2026.
.
[Fuda News] [Thailand – Hospital Visit]
Friends from Afar! Thai Medical Experts Visit Fuda for Exchange and Collaboration

On April 21, a delegation of medical experts from several renowned healthcare institutions in Thailand visited Guangzhou Fuda Cancer Hospital for an exchange visit. President Niu Lizhi, General Manager Jiang Fang, and Vice President Long Xin’an warmly received their Thai counterparts. Both sides engaged in in-depth discussions on cooperation and interaction in the medical field, aiming to enhance mutual understanding, promote the sharing of academic and clinical experience, and work together to improve medical services and bring more hope to patients.

1083E3CF-FB3A-4651-ABBE-36A145D04C5A.png

06D15718-566A-4150-99F1-C80AE2D6989F.jpg

During the visit, the delegation toured the hospital environment and modern facilities, gaining insight into Fuda’s history, culture, and specialty development. They focused particularly on minimally invasive cancer therapies and observed, up close, procedures such as lung tumor cryoablation and vascular interventional treatments. Detailed explanations were provided on the underlying mechanisms, intraoperative procedures, and key considerations. The Thai experts expressed high appreciation for Fuda’s technical maturity and standardized practices in the field of minimally invasive treatment.

6C177F88-0650-4719-BCC1-D886C70A9A2E.jpg

960B7213-21B0-47BB-AA62-E58D5D9AFCDE.jpg

△President Niu Lizhi and Director Liu Shupeng also offered on-site explanations, vividly introducing key technical aspects and clinical applications of ablation therapy.

Following the tour, both sides held a symposium. General Manager Jiang Fang extended a warm welcome to the Thai delegation on behalf of the hospital. She noted that China and Thailand each possess unique cultural heritages and medical traditions—such as Traditional Chinese Medicine and Thai medicine—which create broad opportunities for deeper cooperation in healthcare.

4A8E4DA4-6E77-444F-AB64-BDA8EA5BF7CA.png

Jiang introduced that over 20 years ago, Fuda took the lead in introducing cryoablation technology and successfully applied it in tumor treatment, achieving internationally advanced levels in both clinical practice and academic research, and earning wide recognition. Meanwhile, the hospital continues to uphold innovation while preserving core principles, actively adopting advanced technologies such as NanoKnife ablation, seed implantation, photodynamic therapy, and vascular interventional treatments to continuously strengthen its medical capabilities.

Fuda has also established partnerships with medical institutions across multiple countries and regions, providing systematic pre-hospital, in-hospital, and post-hospital services. In particular, it emphasizes post-treatment rehabilitation management to ensure patients’ survival outcomes and quality of life.

Jiang expressed her hope that through China–Thailand cooperation, high-quality and accessible treatment services can be provided to cancer patients worldwide. She also hopes that every Thai patient, as well as their families and friends visiting China and Fuda, can have a warm and memorable experience.

Vice President Long Xin’an shared clinical experiences involving several Thai cancer patients. Many of these patients have achieved survival of more than 10 years after systematic anti-tumor treatments. He noted that most Thai patients who come for treatment are already in advanced stages and may not benefit significantly from conventional surgery, radiotherapy, or chemotherapy. However, at Fuda, a multidisciplinary team approach—combining local ablation with systemic therapy—often yields significantly better outcomes than single-modality treatments.

4F468433-8EA3-4D6A-A6A3-6556878488D9.png

At the same time, he candidly acknowledged the limitations of current medical treatments. For some severe cases, recurrence and metastasis remain inevitable. “Even when tumors cannot be completely eliminated, we can still help patients achieve ‘living with cancer,’ prolong survival, and improve quality of life,” he said. He expressed hope to continue leveraging professional expertise and high-quality services to benefit more patients in the future.

Among the visitors, Dr. Tawatchai Chuwansombat, Senior Advisor of World Medical Center Hospital, and Ms. Pitchamon Pattamada, Vice Chairperson of Cosmi Co., Ltd., held particularly special roles. Not only are they experienced professionals in Thailand’s medical field, but they are also “witnesses” of Fuda’s care, having previously been family members of patients treated at the hospital. Their personal experiences gave them a deep appreciation of both Fuda’s medical technology and its humanistic care.

1ACD7927-253E-4C1F-A6DB-43ED5C913669.png

They stated that their visit, along with other Thai experts, was also driven by a sense of social responsibility. From the perspective of improving patients’ survival and quality of life, they hope to further strengthen China–Thailand friendship through exchange and cooperation, and jointly build high-quality medical services that offer better patient experiences.

During the meeting, both sides conducted in-depth discussions on teleconsultation services, integrated pre-, in-, and post-hospital care, and post-treatment follow-up and rehabilitation management. They expressed a shared expectation to establish a long-term and stable partnership, promoting complementary strengths and joint development in academic exchange, clinical technology, and patient services.

43C0EEAA-D7C1-483D-8032-2E633FFCCD8A.jpg

At the conclusion of the visit, both sides exchanged gifts as a token of friendship. The Thai delegation presented a sacred Thai totem—the Garuda—symbolizing their wish for Fuda to “soar high and achieve a bright future.” This meaningful gift stands as a testament to the strong and growing friendship between the two countries in the medical field.

Friendship transcends mountains and seas, and cooperation heals the future. This visit by the Thai medical delegation not only deepened mutual understanding and trust but also laid a solid foundation for long-term cooperation in cancer treatment between China and Thailand. In the future, Guangzhou Fuda Cancer Hospital will continue to uphold the principles of openness, sharing, and innovation, working hand in hand with medical institutions in Thailand and around the world to contribute greater wisdom and strength to global health.



Click to learn more patient stories:
>>> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

21/04/2026

APR.21.2026.
.
[Minimally Invasive Treatment] [Melanoma – Cryoablation]
>>>Hydrodissection-Assisted Cryoablation for 93-Year-Old Melanoma Patient> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

14/04/2026

Apr.14.2026.
.
【Paitent’s Story】【Malaysia - Liver Cancer - Interventional Chemotherapy】
>>>Stage IV Liver Cancer: No Surgery, Better Sleep After Interventional Therapy> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

AnnouncementTo all FUDA Cancer Hospital patients;Please be informed that there will be a public holiday in China from Ma...
13/04/2026

Announcement

To all FUDA Cancer Hospital patients;

Please be informed that there will be a public holiday in China from May 1 to May 5, 2026.

In line with this, we kindly advise scheduling travel or visits before or after these dates to avoid any inconvenience or delays.

Thank you.

10/04/2026

Apr.10.2026.
.
【Paitent’s Story】【Antigua – Oropharyngeal Cancer – Arterial Infusion Embolization】
>>>Oropharyngeal Cancer Patient Refuses Surgery: Rapid Improvement After treated in Fuda> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

08/04/2026

Urgent Hiring for Medical Assistant

Job description
Ability: Excellent communication and interpersonal skills to interact with patients, health care providers, and other staff members. Independent, hard-working, positive, patient, problem-solving, and self-motivated. A medical background is preferred.

Experience : Unlimited

Duties :
1. Collect the patient's medical reports and ask patient's medical history
2. Summarize patient's case and communicate with your doctor
3. Set up an appointment and explain the treatment plan to the patient
4. Manage patient files
5. Other tasks given by leaders

Welfare:
1. Birthday Gift
2. Connect with the Chinese market
3. Welcome graduates for internship

Job Types : Contract, Full-time
Contract length : 12 months
Salary : Up to PHP 52,000 per month

Benefits:
Maternity leave
Professional development

Working Hours:Monday to Friday 9 to 5pm On call

Location:
FUDA Cancer Hospital Service Center in Makati

Supplemental pay types:
Attendance bonus
Commission pay

Language:
English
Chinese is a preference

Expected Start Date: ASAP
Please send your CV to consultationmalaysia@fudahospital.com if you are interested.

27/03/2026

Mar.27.2026.
.
【Minimally Invasive Treatment】【Lung Nodule -Cryoablation】
>>>Cryoablation of Lung Nodule in an 82-Year-Old Veteran> https://en.fudahospital.com/

You can contact us through the following channels:
☎️ TEL: +63 917 775 3426.
🌟 WhatsApp: +63 917 775 3426.
🌍 Website: https://en.fudahospital.com/

Address

Unit 2522, 25th Floor, Centuria Medical Makati Building
Makati
1210

Alerts

Be the first to know and let us send you an email when Fuda Cancer Hospital - Philippines posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Share

Category

Our Story

Fuda Cancer Hospital South District and Fuda Cancer Hospital North District (collectively, “Fuda Cancer Hospital”) are located in Guangzhou, in the south of China. Both hospitals are modern and specialized cancer centers that are recognized for their minimally invasive therapies and innovative treatments that provide an effective alternative to the traditional treatment of chemotherapy/radiation/surgery. Fuda Cancer Hospital is affiliated with the Chinese Academy of Sciences’ Guangzhou Institute of Biomedicine and Health. The hospitals are teaching hospitals of Jinan University School of Medicine. In 2010, the central government designated the hospitals as nationally important clinics and awarded a five million RMB grant to them. The honorary president of the hospital is Academician Mengchao Wu, and the president is Professor Kecheng Xu, a renowned and highly respected specialist of general oncology and gastroenterology. Fuda Cancer Hospital focuses on the diagnosis and treatment of liver, lung, breast, nasopharyngeal, colorectal, uterus, stomach, esophageal, pancreatic, tongue, prostate, skin, larynx, and lymphoma cancers, as well as many others. The hospital insists on providing patient care and services and adopting an individualized approach in the treatment of patients based on their individual conditions. By combining conventional treatment with newly developed technologies and traditional Chinese medicine, the hospital is equipped to treat patients with a complete spectrum of available therapies, from the traditional to the cutting-edge. Besides the conventional treatments for cancer (surgery, chemotherapy and radiotherapy) the hospital has brought together innovative and proven new technologies such as Nano Knife Therapy, Interventional Hepasphere, cryosurgical ablation (CSA), vascular interventional therapy, Cancer Microvessel Intervention (CMI), photodynamic therapy, seed knife brachytherapy, radiofrequency ablation and bioimmunotherapy. The hospital prides itself on using a “3C+P” approach when treating patients: CSA, CMI, combined immunotherapy for cancer (CIC), and personalized therapy. So far, Fuda Cancer Hospital has performed more than 12,000 cases of cryosurgical ablation, and it performs the most number of cryosurgical ablations annually in the world. Dr. Franco Lugnani, the president of the International Society of Cryosurgery, has lauded Fuda for its efforts. Furthermore, the International Society of Cryosurgery designated the hospital as a training center for doctors from the Asian-Pacific region who are interested in cryosurgery. The hospital’s concept and diagnostic techniques have gained a great reputation from countries throughout southeast Asia, as well as the United States, the United Kingdom, Spain, Denmark, Netherlands, and other countries. Fuda is also a Joint Commission International (JCI) accredited, JCI is from the USA that monitors all private and government hospitals in the world to follow the international standard patient and treatment safety protocols. Fuda Makati Satellite office offers second opinion consultation to review and provide other treatment options besides the traditional surgery, chemotherapy and radiotherapy. To know more about our services and capabilities please go through of our page and then contact us. Thank you and Mabuhay!!!